title: The efficacy of guanxinning injection in treating angina pectoris: systematic review and meta-analysis of randomized controlled trials.
abstract: Objective. The randomized controlled trials (RCTs) on Guanxinning injection (GXN) in treating angina pectoris were published only in Chinese and have not been systematically reviewed. This study aims to provide a PRISMA-compliant and internationally accessible systematic review to evaluate the efficacy of GXN in treating angina pectoris. Methods. The RCTs were included according to prespecified eligibility criteria. Meta-analysis was performed to evaluate the symptomatic (SYMPTOMS) and electrocardiographic (ECG) improvements after treatment. Odds ratios (ORs) were used to measure effect sizes. Subgroup analysis, sensitivity analysis, and metaregression were conducted to evaluate the robustness of the results. Results. Sixty-five RCTs published between 2002 and 2012 with 6064 participants were included. Overall ORs comparing GXN with other drugs were 3.32 (95% CI: [2.72, 4.04]) in SYMPTOMS and 2.59 (95% CI: [2.14, 3.15]) in ECG. Subgroup analysis, sensitivity analysis, and metaregression found no statistically significant dependence of overall ORs upon specific study characteristics. Conclusion. This meta-analysis of eligible RCTs provides evidence that GXN is effective in treating angina pectoris. This evidence warrants further RCTs of higher quality, longer follow-up periods, larger sample sizes, and multicentres/multicountries for more extensive subgroup, sensitivity, and metaregression analyses.
authors: State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China.
authors: Yongliang
authors: Y
authors: Jia
authors: Siu-Wai
authors: SW
authors: Leung
authors: Ming-Yuen
authors: MY
authors: Lee
authors: Guozhen
authors: G
authors: Cui
authors: Xiaohui
authors: X
authors: Huang
authors: Fongha
authors: F
authors: Pan
references: Stat Med. 2002 Jun 15;21(11):1539-58
references: 12111919
references: Circulation. 1979 Mar;59(3):607-9
references: 761341
references: Int J Cardiol. 2007 Sep 14;121(1):9-22
references: 17363091
references: BMJ. 1999 Jul 17;319(7203):160-1
references: 10406751
references: J Clin Epidemiol. 2001 Oct;54(10):1046-55
references: 11576817
references: Rapid Commun Mass Spectrom. 2011 Jun 15;25(11):1661-74
references: 21594942
references: Am J Chin Med. 2002;30(1):173-6
references: 12067091
references: J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Sep 15;873(1):51-8
references: 18718823
references: Phys Ther. 2009 Sep;89(9):873-80
references: 19723669
references: Trends Pharmacol Sci. 2008 Jul;29(7):331-2
references: 18502520
references: Biometrics. 1994 Dec;50(4):1088-101
references: 7786990
references: Control Clin Trials. 1996 Feb;17(1):1-12
references: 8721797
references: Circulation. 1998 Jan 27;97(3):282-9
references: 9462531
references: Int J Cardiol. 2012 Jun 14;157(3):330-40
references: 21251721
references: Natl Vital Stat Rep. 2008 Apr 24;56(10):1-120
references: 18512336
references: Biometrics. 2000 Jun;56(2):455-63
references: 10877304
references: Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2010 Feb;22(2):109-12
references: 20170617
references: Circulation. 2005 Dec 6;112(23):3547-53
references: 16330695
references: Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4826-31
references: 18344322
references: Stat Med. 2002 Jun 15;21(11):1559-73
references: 12111920